Science Explorer Back to mapMap
Discussion
Researcher · Institut Claudius Regaud · France

Roland Bugat

Roland Bugat publishes mostly in Oncology, Molecular Biology and Pulmonary and Respiratory Medicine, on topics such as Cancer Treatment and Pharmacology, Colorectal Cancer Treatments and Studies and Cancer therapeutics and mechanisms.

ORCID 0000-0001-7258-9019 OpenAlex
World rank
#1,196,610
of 7,710,434 ranked researchers
Rank in France
#55,143
of 324,115
Works
260
Citations
10k
Citations per work
38.3
h-index
48
i10-index 121Top 4.1% in Oncology
Roland Bugat

What does Roland Bugat research?

Roland Bugat's work is mostly in Medicine (54%), Biochemistry, Genetics and Molecular Biology (9%).

Health Sciences: 140 works · 53.7% of their workMedicine: 140 works · 53.7% of their workOncology: 77 works · 29.5% of their workPulmonary and Respiratory Medicine: 21 works · 8.1% of their workSurgery: 21 works · 8.0% of their workPathology and Forensic Medicine: 11 works · 4.2% of their workHematology: 10 works · 3.9% of their workEverything else: 98 works · 37.6% of their workLife Sciences: 23 works · 8.7% of their workBiochemistry, Genetics and Molecular Biology: 23 works · 8.7% of their workMolecular Biology: 23 works · 8.7% of their workTHEIR WORKRoland Bugat260works
Life Sciences9%Health Sciences54%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine14053.7%
  2. Everything else9837.6%
    1. Biochemistry, Genetics and Molecular Biology238.7%
  1. 1Oncology30% of their works
  2. 2Molecular Biology9% of their works
  3. 3Pulmonary and Respiratory Medicine8% of their works
  4. 4Surgery8% of their works
  5. 5Pathology and Forensic Medicine4% of their works
  6. 6Hematology4% of their works

Research topics

Which keywords describe Roland Bugat's research?

The keywords of their largest research topics: Chemotherapy, Chemotherapy-Induced Peripheral Neuropathy, Taxanes, Cetuximab, KRAS Mutations, DNA, Topoisomerases and Immunotherapy.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Chemotherapy1456 topics
  2. Chemotherapy-Induced Peripheral Neuropathy511 topic
  3. Taxanes511 topic
  4. Cetuximab441 topic
  5. KRAS Mutations441 topic
  6. DNA371 topic
  7. Topoisomerases371 topic
  8. Immunotherapy332 topics
  9. Gastric Cancer302 topics
  10. Survival Analysis302 topics
  11. Genomic Profiles181 topic
  12. Small-Cell Lung Cancer181 topic
  13. Cisplatin161 topic
  14. Nephrotoxicity161 topic
  15. Cytoreductive Surgery151 topic
  16. Endoscopic Resection151 topic
  17. Intraperitoneal Chemotherapy151 topic
  18. Molecular Characterization151 topic
  19. Pancreatic Cancer151 topic
  20. Surgical Complications151 topic

Where does Roland Bugat work?

Roland Bugat's main affiliation in the publication record is Institut Claudius Regaud, France.

How many publications and citations does Roland Bugat have?

OpenAlex counts 260 works and 9,967 citations for Roland Bugat, an h-index of 48, ranking #1,196,610 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Roland Bugat. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.